Financhill
Back

Solid Biosciences Quote, Financials, Valuation and Earnings

Buy
59

SLDB
Solid Biosciences

Last Price:
9.67
Seasonality Move:
8.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Solid Biosciences Price Quote

$9.67
-0.29 (-2.91%)
(Updated: May 15, 2024 at 6:55 PM ET)

Solid Biosciences Key Stats

Buy
59
Solid Biosciences (SLDB) is a Buy

Day range:
$9.63 - $10.16
52-week range:
$1.81 - $15.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
13.39
P/B ratio:
2.98%

Volume:
92.3K
Avg. volume:
191.7K
1-year change:
57.59%
Market cap:
$377.1M
Revenue:
$0
EPS:
$-4.84

How Much Does Solid Biosciences Make?

Data Unavailable

Is Solid Biosciences Growing As A Company?

Data Unavailable

Solid Biosciences Stock Price Performance

What Is Solid Biosciences 52-Week High & Low?

Solid Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Solid Biosciences?

  • How Much Debt Does Solid Biosciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Solid Biosciences Have?
    Cash and short term investments quarterly total is $123.6M
  • What Is Solid Biosciences’s Book Value Per Share?
    Book value per share is 6.20

Is Solid Biosciences Cash Flow Positive?

  • What Is SLDB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$94.2M
  • What Is Solid Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $3.1M
  • What Is Solid Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $9.7M

Solid Biosciences Return On Invested Capital

Data Unavailable

Solid Biosciences Earnings Date & Stock Price

Solid Biosciences Competitors

  • Who Are Solid Biosciences's Competitors?
    Below is a list of companies who compete with Solid Biosciences or are related in some way:
    • Capricor Therapeutics Inc (CAPR)
    • Catalyst Pharmaceuticals Inc (CPRX)
    • Pfizer Inc (PFE)
    • PTC Therapeutics Inc (PTCT)
    • Sarepta Therapeutics Inc (SRPT)

Solid Biosciences Dividend Yield

Data Unavailable

Solid Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0.25%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 17.78
Upside from Last Price: 78.49%

Major Shareholders

  • How many SLDB shares are owned by institutional investors?
    24.8M SLDB shares are owned by institutional investors
  • How many SLDB shares are owned by insiders?
    8.1M SLDB shares are owned by insiders